DXA is unable to measure differential changes in bone density and microstructure induced by metabolic bone diseases.

被引:0
|
作者
Cory, E. [1 ]
Nazarian, A. [1 ]
Van der Zwaal, P. [1 ]
Hoogwater, F. [1 ]
Bohanske, M. [1 ]
Snyder, B. [1 ]
机构
[1] Harvard Univ, Sch Med, BIDMC, OBL, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S352 / S352
页数:1
相关论文
共 50 条
  • [1] Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models
    Nazarian, A.
    Cory, E.
    Mueller, R.
    Snyder, B. D.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 123 - 132
  • [2] Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models
    A. Nazarian
    E. Cory
    R. Müller
    B. D. Snyder
    Osteoporosis International, 2009, 20 : 123 - 132
  • [3] Bone scan in metabolic bone diseases. Review
    Abdelrazek, Saeid
    Szumowski, Piotr
    Rogowski, Franciszek
    Kociura-Sawicka, Agnieszka
    Mojsak, Malgorzata
    Szorc, Malgorzata
    NUCLEAR MEDICINE REVIEW, 2012, 15 (02) : 124 - 131
  • [4] Bone Mineral Density, Trabecular Bone Score and proximal Femur 3D-DXA Analysis in Psoriatic Diseases.
    Toussirot, Eric
    Winzenrieth, Renaud
    Desmarets, Maxime
    Aubin, Francois
    Dumoulin, Gilles
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 241 - 242
  • [5] Clinical performances of biochemical markers of bone resorption in metabolic bone diseases.
    Dorizzi, RM
    Bertoldo, F
    Zanini, M
    Caputo, M
    Gasperi, E
    Furlan, F
    CLINICAL CHEMISTRY, 1997, 43 : 636 - 636
  • [6] The reactive changes of the bone marrow in the septic diseases.
    Anselmino, KI
    VIRCHOWS ARCHIV FUR PATHOLOGISCHE ANATOMIE UND PHYSIOLOGIE UND FUR KLINISCHE MEDIZIN, 1926, 262 (03): : 766 - 782
  • [7] Serum Activin-A levels in metabolic bone diseases.
    Nuti, R
    Martini, G
    Florio, G
    Valenti, R
    Salvadori, S
    Picchi, A
    Petraglia, F
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S254 - S254
  • [8] DISCRIMINATION OF BONE-DENSITY CHANGES WITH QCT AS COMPARED WITH DXA
    SMITH, B
    SCHULZ, EE
    BAYLINK, DJ
    CLINICAL RESEARCH, 1992, 40 (01): : A70 - A70
  • [9] Pathological and metabolic bone diseases. Clinical importance for fracture treatment
    Oheim, R.
    UNFALLCHIRURG, 2015, 118 (12): : 1007 - 1016
  • [10] DIFFERENTIAL-DIAGNOSIS OF METABOLIC BONE-DISEASES
    DAMBACHER, MA
    LANGLOTZ, M
    OLAH, AJ
    RUEGSEGGER, P
    ORTHOPADE, 1982, 11 (02): : 35 - 46